Page 742 - TNFlipTest

NP42 Nephrology References Toronto Notes 2019 References
Adler SG, Salant DJ. An outline of essential topics in glomerular pathophysiology, diagnosis and treatment for nephrology trainees. Am J Kidney Dis 2003;42:395-418. Androgue HJ, Madias NM. Management of life threatening acid-base disorders part I. NEJM 1999;338:26-33.
Androgue HJ, Madias NM. Management of life threatening acid-base disorders part II. NEJM 1999;338:107-111.
Androgue HJ, Madias NE. Hyponatremia. NEJM 2000;342:1581-1589.
Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo-controlled trial. Lancet 2011;377:2181-2192.
Barnett AH, Bain SC, Bouter P, et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. NEJM 2004;351:1952-1961.
Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal cardiovascular outcomes in patients with type 2 diabetes and nephropathy. NEJM 2001;345:861-869.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Can J Diabetes 2013;37(suppl 1):S1-S212.
Churchill DN, Blacke PG, Jindal KK, et al. Clinical practice guidelines for initiation of dialysis. Canadian Society of Nephrology. J Am Soc Nephrol 1999;10(Suppl 13):S238-291.
Cooper CJ, Murphy DP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. NEJM 2014;370:13-22.
Donadio JV, Grande JP. Medical progress: IgA nephropathy. NEJM 2002;347:738-748.
Elliott MJ, Ronksley PE, Clase CM, et al. Management of patients with acute hyperkalemia. CMAJ 2010;182:1631-1635
Gabow PA. Autosomal dominant polycystic kidney disease. NEJM 1993;329:332-342.
Greenberg AR. Primer on kidney diseases, 3rd ed. San Diego: Academic Press, 2001.
Hakim R, Lazarus M. Initiation of dialysis. J Am Soc Nephrol 1995;6:1319-1328.
Halperin ML, Goldstein MB, Kersey R, et al. Fluid, electrolyte, and acid-base physiology: a problem-based approach, 3rd ed. New York: Harcourt Brace, 1998.
Halperin ML, Kamel K. Potassium. Lancet 1998;352:135-140.
Heerspink HJ, Desai M, Jardine M, Balis D, Meininger G, Perkovic V. Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects. J Am Soc Nephrol 2017;28(1):368-375. Hudson BG, Tryggvason K, Sundaramoorthy M, et al. Mechanisms of disease: Alport’s syndrome, goodpasture’s syndrome, and type IV collagen. NEJM 2003;348:2543-2556.
Johnson CA, Levey AS, Coresh J, et al. Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers. Am Fam Phys 2004;70:1091-1097. Johnson RJ, Feehally J (editors). Comprehensive clinical nephrology. New Nork: Mosby, 1999.
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification: 2000 executive update. Available from: http://www. kidney.org/professionals/dogi/kdogi/toc.htm. Keane WF, Garabed E. Proteinuria, albuminuria, risk assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Amer J Kid Dis 1999;33:1004-1010.
Lewis EJ, Hunsicker LG, Bain RP, et al. The effects of angiotensin-converting enzyme inhibition on diabetic nephropathy. NEJM 1993;329:1456-1462.
McFarlane P, Tobe S, Houlden R, et al. Nephropathy: Canadian Diabetes Association clinical practice guidelines expert committee. 2003. Available from:
Moist LM, Troyanov S, White CT, et al. Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis 2013;62(5):860-73.
Myers A. Medicine, 4th ed. Baltimore: Lipincott Williams & Wilkins, 2001.
ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. NEJM 2008;358:1547-1559.
Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. NEJM 2002;346:305-310.
Schreiber M. Seminars for year 3 University of Toronto Medicine clinical clerks on medicine: hyponatremia and hypernatremia. October 29, 2002.
Smith K. Renal disease: a conceptual approach. New York: Churchill Livingstone, 1987.
Thadhani R, Pascual M, Bonventre JV. Acute renal failure. NEJM 1996;334:1448-1460.
Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. NEJM 1999;341(23):1725-30.